Analysis
Jio Platforms: Elephant in the room
India’s Jio Platforms has received substantial private equity backing as it looks to build a digital platform that is all things to all people, from cable to retail. Will it succeed?
Japan carve-outs: Profit from the core
Private equity firms hoping for a coronavirus-driven uptick on Japanese corporate carve-outs must be patient – and come armed with considered value creation plans when the time arrives
ESG and VC: Deferred dialogue
Institutional LPs are traditionally less engaged with VC versus PE when it comes to responsible investment standards. A multitude of drivers are changing this, but not quickly
China mezzanine: Not the norm
China’s local currency mezzanine capital space is underpenetrated, underpopulated and different to comparable strategies elsewhere. A handful of domestic GPs have begun to get traction. Will others follow?
Coronavirus & Vietnam: Hobbled winner
A successful COVID-19 containment plan has underlined Vietnam’s status as a leading investment destination in Southeast Asia. GPs are impressed but still hamstrung
India-China regulation: Punching bag
Chinese venture capital investors have become an increasingly significant presence in India’s venture capital ecosystem, but a recent regulatory reform calls their participation into question
China enterprise software: PaaS vs SaaS
Platform-as-a-service has become the flavor of the month in China’s software industry, but there can be a big difference between what start-ups are and what they claim to be
Asia private debt: Inflection point?
With other pools of capital running dry for many companies, private debt has become a more appealing proposition. Institutional funds have a chance to impose themselves on a bank-driven market
Australia's mid-market: The middlemen
Pure proprietary deals are a rarity in Australia’s mid-market. Most opportunities pass through a fragmented network of advisors, which means private equity firms must get noticed to stay relevant
Coronavirus & MAC clauses: Devil in the details
Business breakdowns caused by COVID-19 have spurred investors to re-examine their legal options with deals in pre-close limbo. That could spark a major evolution in M&A contracting
Portfolio: Navis Capital Partners & Hanoi French Hospital
Navis Capital Partners has taken a boutique private hospital to a new level of competence and professionalism just in time for the biggest healthcare emergency in living memory
Coronavirus & Australia VC: In SaaS we trust
Enterprise services start-ups with recurring revenue are well positioned, but mid-cap players could become vulnerable
Coronavirus & Southeast Asia VC: Unpleasant surprises
Start-ups in Southeast Asia have few capital sources, so it helps that the region’s VCs are well-funded – assuming they are ready to invest
Coronavirus & North Asia VC: Diverging fortunes
Speed of response to COVID-19 has led to differing outcomes for VC investment in Korea and Japan. But structural issues are also a factor
Coronavirus & India VC: Struggling to work
Investors don’t expect business activity in India to resume until the second half. Many start-ups will be desperate for capital before then
Coronavirus & China VC: Bifurcation point
China might be emerging from the grip of COVID-19, but many start-ups face a long battle. This is when VCs find out who the winners are
1Q analysis: Impact winter
As the coronavirus outbreak escalated into a global pandemic, what was a problem for China investors quickly spread into other geographies. Fundraising, investment and exits inevitably took a hit
Coronavirus & capital calls: Time to draw?
With GPs and LPs placing a premium on liquidity, there is more scrutiny of capital call processes. Some managers are pushing for changes to documentation, but will investors relent?
Southeast Asia VC: Different strokes
Ahead of an expected increase in LP interest, Southeast Asian VCs vie to stand out from the crowd by fine-tuning strategies to capture the virtues of both generalists and specialists
Jumpstarted: Investors target China's EV charging networks
Telaidian’s recent Series A round underlines the opportunities in China’s electric vehicle charging space. While growth seems certain, some industry dynamics have yet to play out
Portfolio: Capital Square Partners and Aegis/StarTek
Capital Square Partners’ acquisition of Indian business processing outsourcing (BPO) player Aegis ultimately helped two different companies find global relevance after a turbulent and disruptive decade
China LP defaults: Battle of wills
A protracted legal dispute between a cross-border private equity firm and a Chinese investor is a reminder of the difficulties that can arise over fund defaults. Negotiation is always the preferred course of action
Coronavirus & secondaries: Niche dilemmas
Anecdotal feedback from secondaries professionals reveals a quick onset of stagnation in the market due to COVID-19. Creative workarounds are not impossible, but almost
GP profile: GTJA Investment Group
Having established itself as a leading player in the renminbi space, China healthcare sector specialist GTJA Investment Group now wants to prove its worth to overseas LPs
